IL33 and allergic disease: Although further studies are needed to address how IL-33-ST2-ILC2s axis is negatively regulated in pathological situations in more detail, selective targeting of IL-33-ST2-ILC2s axis would be a promising strategy for the treatment of allergic diseases.